Short answer: oral NMN reliably raises blood NAD+ in human trials. Beyond that, the functional findings are real but narrower than commonly advertised: improved muscle insulin sensitivity in prediabetic postmenopausal women, improved aerobic capacity in amateur runners, and changes in muscle function in older men. The trials are small and short, which is the honest caveat that belongs alongside every one of those results.
How NMN works
NMN is converted to NAD+ intracellularly by the NMNAT enzyme in a single step, which is why it is described as a direct precursor.
NAD+ availability declines with age. Zhu and colleagues (2015) measured NAD+ directly in healthy human brain using magnetic resonance spectroscopy and confirmed an age-related decline alongside a shift in redox state. That decline is the premise for the whole category.
The 2021 Science trial — what it actually found
Yoshino and colleagues (2021), published in Science, gave 250 mg of oral NMN daily for 10 weeks in a randomised, placebo-controlled trial. The primary finding was improved muscle insulin sensitivity, alongside changes in muscle gene expression related to remodelling.
Two corrections to how this page previously described that study. The participants were postmenopausal women with prediabetes, not healthy older women — which matters, because insulin-sensitivity improvements in a prediabetic group do not transfer automatically to metabolically healthy people. And the trial did not report improvements in walking speed or general physical performance; we previously said it did, and that was wrong.
It is also a small study — 25 participants. It is an important trial because it is rigorous and in humans, not because it is large.
Aerobic capacity and muscle function
Two further human trials are worth knowing, and neither is the one this page used to cite.
Liao and colleagues (2021), in the Journal of the International Society of Sports Nutrition, randomised amateur runners to NMN or placebo for six weeks and reported dose-dependent improvements in aerobic capacity, which the authors attributed to increased oxygen utilisation by skeletal muscle.
Igarashi and colleagues (2022), in npj Aging, gave chronic NMN to healthy older men and found blood NAD+ levels rose, with changes in some measures of muscle function.
An earlier version of this page attributed a muscle-performance finding to a paper in Frontiers in Aging that turned out to be a one-page editorial about lipids. That citation has been removed and replaced with the two trials above.
What is not established
Worth stating plainly, because the category oversells. There is no human evidence that NMN extends lifespan. The trials run weeks to months, not years, so long-term safety is not established. Participant numbers are in the dozens. And the results come from specific populations — prediabetic women, amateur runners, older men — which is not the same as a general effect in everyone.
The regulatory position in the US is also contested: since 2022 the FDA has taken the view that NMN is excluded from the dietary supplement definition, and that has been disputed since. Detail in NMN Dosage and Side Effects.
Why purity matters
NMN exists as a biologically active beta anomer and an inactive alpha form; only beta-NMN is efficiently converted by NMNAT. A purity specification tells you how much of what you paid for is the active isomer rather than byproduct. AE·ORA NMN is 99.9% beta-NMN at 500 mg per capsule, and every batch is third-party tested — see the Science page.
Frequently Asked Questions
Quick answers to the questions readers most often ask.
Does NMN actually work in humans?
Oral NMN reliably raises blood NAD+ in randomised human trials. Functional findings are narrower: improved muscle insulin sensitivity in prediabetic postmenopausal women, improved aerobic capacity in amateur runners, and changes in muscle function in older men. All were small, short trials in specific populations.
What are the benefits of taking NMN?
Documented in human trials: raised blood NAD+, improved muscle insulin sensitivity in a prediabetic group, and improved aerobic capacity in trained amateur runners. Not documented in humans: lifespan extension, or general performance benefits in metabolically healthy people.
How much NMN should I take per day?
Human trials have used roughly 250 mg to 900 mg daily, most commonly in the morning. Dose-ranging work suggests blood NAD+ increases are not indefinitely dose-dependent, so more is not automatically better. Speak to a clinician first if you take prescription medication.
Is NMN better than NAD+ as a supplement?
NMN enters the NAD+ pathway in a single enzymatic step, which is a mechanistic argument for efficiency, and the human trial evidence sits with precursors rather than with oral NAD+ itself. Which suits you depends on formulation and goal rather than one being categorically superior.
How long does NMN take to work?
Blood NAD+ rises within weeks of consistent dosing. Functional outcomes were measured at six to twelve weeks in the trials that measured them at all, so judge it on that timescale rather than on a fortnight.
References
Every reference below has been verified against PubMed. Study populations are stated in the text.
- Zhu XH et al. In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences. PNAS. 2015.
- Yoshino M et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021.
- Liao B et al. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomised, double-blind study. J Int Soc Sports Nutr. 2021.
- Igarashi M et al. Chronic nicotinamide mononucleotide supplementation elevates blood NAD levels and alters muscle function in healthy older men. npj Aging. 2022.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
